Answers are grounded in this paper and cite their sources.
Experimental study demonstrates metal-free oxidative cyclization of chalcones to flavones using DBU·HI3, highlighting an efficient route for heterocyclic drug synthesis.
An efficient and operationally simple protocol has been developed for the synthesis of biologically significant flavones and 2-arylquinolin-4-ones (azaflavones). The methodology utilizes a bench-stable organocatalyst, DBU⋅HI3, to drive the oxidative cyclization of substituted 2’-hydroxychalcones and 2’-aminochalcones. Optimization studies revealed that a 15 mol % catalyst loading in DMSO at 110 °C selectively promotes rapid dehydrogenative cyclization within 1-2.5 h, suppressing side products like flavanones. Conversely, protic or nonpolar solvents resulted in poor conversions or incomplete aromatization. This metal-free strategy tolerates a broad range of substrates, including electron-donating, electron-withdrawing, and selected heteroaryl groups, delivering the target frameworks in exceptional isolated yields (up to 94% for flavones and 91% for azaflavones). The synthesized products were structurally confirmed by spectroscopic analysis, and the efficient metal-free protocol provides a practical alternative to conventional transition-metal-based oxidative systems.
No takes yet. Share an insight, caveat, or question.
Gawade et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: